Article metrics

Download PDFPDF

PO003/#269  Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2024

AbstractFullPdf
Nov 2023148031
Dec 202398017
Jan 20247205
Feb 202483010
Mar 202481025
Apr 20247306
May 202481028
Jun 202438010
Total6740132